131 related articles for article (PubMed ID: 3157585)
41. Selective inhibition by ketanserin and spiroperidol of 5-HT-induced myometrial contraction.
Ichida S; Hayashi T; Terao M
Eur J Pharmacol; 1983 Dec; 96(1-2):155-8. PubMed ID: 6662193
[TBL] [Abstract][Full Text] [Related]
42. Photoaffinity probes for serotonin and histamine receptors. Synthesis and characterization of two azide analogues of ketanserin.
Wouters W; Van Dun J; Leysen JE; Laduron PM
J Biol Chem; 1985 Jul; 260(14):8423-9. PubMed ID: 3874207
[TBL] [Abstract][Full Text] [Related]
43. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
De Souza EB; Kuyatt BL
Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
[TBL] [Abstract][Full Text] [Related]
44. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
45. Modulation of the serotonin S2-receptor in brain after chronic lithium.
Wajda IJ; Banay-Schwartz M; Manigault I; Lajtha A
Neurochem Res; 1986 Jul; 11(7):949-57. PubMed ID: 2944024
[TBL] [Abstract][Full Text] [Related]
46. Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex.
Torda T; Murgas K; Cechova E; Kiss A; Saavedra JM
Brain Res; 1990 Sep; 527(2):198-203. PubMed ID: 1701336
[TBL] [Abstract][Full Text] [Related]
47. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
48. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors.
Pazos A; Hoyer D; Palacios JM
Eur J Pharmacol; 1984 Nov; 106(3):531-8. PubMed ID: 6519174
[TBL] [Abstract][Full Text] [Related]
49. Influence of lipid peroxidation on [3H]ketanserin binding to 5-HT2 prefrontal cortex receptors.
Rego AC; Oliveira CR
Neurochem Int; 1995 Dec; 27(6):489-96. PubMed ID: 8574178
[TBL] [Abstract][Full Text] [Related]
50. Characterization of [3H]paroxetine binding to rat cortical membranes.
Habert E; Graham D; Tahraoui L; Claustre Y; Langer SZ
Eur J Pharmacol; 1985 Nov; 118(1-2):107-14. PubMed ID: 2935409
[TBL] [Abstract][Full Text] [Related]
51. Characterization of [3H]YM060, a potent and selective 5-HT3 receptor radioligand, in the cerebral cortex of rats.
Akuzawa S; Miyata K; Fukutomi H
Eur J Pharmacol; 1995 Jul; 281(1):37-42. PubMed ID: 8566114
[TBL] [Abstract][Full Text] [Related]
52. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
Dewar KM; Reader TA; Grondin L; Descarries L
Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
[TBL] [Abstract][Full Text] [Related]
53. Harmine reverses the inhibition of lordosis by the 5-HT2 antagonists pirenperone and ketanserin in the female rat.
Mendelson SD; Gorzalka BB
Pharmacol Biochem Behav; 1986 Jul; 25(1):111-5. PubMed ID: 2944128
[TBL] [Abstract][Full Text] [Related]
54. Non-serotonergic 3H-ketanserin binding sites in human platelets: characteristics and interaction with calcium antagonists.
Oliva D; Pocchiari F; Allievi L; Rovati GE; Nicosia S
Pharmacol Res; 1992 Sep; 26(2):187-99. PubMed ID: 1409259
[TBL] [Abstract][Full Text] [Related]
55. Binding characteristics of [3H]ketanserin for serotonin-2 receptor in the rabbit platelet.
Tsuchihashi H; Yagi N; Kimura M; Shirota K; Kinami J; Nagatomo T
J Pharmacobiodyn; 1991 Aug; 14(8):461-6. PubMed ID: 1663547
[TBL] [Abstract][Full Text] [Related]
56. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.
Leysen JE; Niemegeers CJ; Van Nueten JM; Laduron PM
Mol Pharmacol; 1982 Mar; 21(2):301-14. PubMed ID: 7099138
[No Abstract] [Full Text] [Related]
57. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
Karkanias GB; Etgen AM
Mol Pharmacol; 1994 Mar; 45(3):509-16. PubMed ID: 7908407
[TBL] [Abstract][Full Text] [Related]
58. Human striosomes are enriched in 5-HT2A receptors: autoradiographical visualization with [3H]MDL100,907,[125I](+/-)DOI and [3H]ketanserin.
López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
Eur J Neurosci; 1999 Oct; 11(10):3761-5. PubMed ID: 10564383
[TBL] [Abstract][Full Text] [Related]
59. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
[TBL] [Abstract][Full Text] [Related]
60. Metabolism of [3H]noradrenaline by the isolated rat uterus.
Fernández-Pardal J; Gimeno MF; Gimeno AL
Can J Physiol Pharmacol; 1981 Dec; 59(12):1245-9. PubMed ID: 7199966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
